Abstracts

EVALUATION OF POTENTIAL DRUG-DRUG INTERACTIONS BETWEEN ISLATRAVIR AND LENACAPAVIR

Co-administration of islatravir (ISL), a nucleoside reverse transcriptase translocation inhibitor, and lenacapavir (LEN), a capsid inhibitor, has the potential to offer a safe and efficacious oral once weekly regimen for the treatment of HIV-1 infection. ISL is not a substrate of cytochrome P450 (CYP) enzymes and is primarily metabolized via adenosine deaminase, with significant elimination…

SERUM NEUROFILAMENT AS A MARKER OF WHITE MATTER INJURITY IN HIV DISEASE

White matter degradation in HIV disease partly reflects legacy effects of untreated infection. Despite effective therapy, persistent immune activation may contribute to further neurodegeneration. Neurofilament light (NFL) is a biomarker of axonal injury that can be measured in biofluids, but direct correlation with MRI measures of white matter integrity in HIV has not been investigated.…

EFFECTS OF AIR POLLUTANTS ON NEUROIMAGING MEASURES DIVERGE BY HIV STATUS

The Lancet Commission on Public Health attributes about 1 in 6 deaths to pollution related factors. The U.S. National Assessment of the Potential Consequences of Climate Variability and Change predicts that individuals living with HIV (PLWH) will be exceptionally vulnerable to climate-sensitive health outcomes. Most literature on HIV and pollution examines international cohorts, emphasizing childhood…

BRAIN VOLUMETRICS DIFFER BY FIEBIG STAGE IN ACUTE INFECTION

People with chronic HIV exhibit neuroimaging abnormalities compared to people without HIV (PWOH), including lower regional brain volumes. Whether volumetric differences exist during acute HIV (AH) is unknown. The present study examined brain volume by Fiebig stage in a large sample of people with AH (PWAH) enrolled in RV254/SEARCH 010, compared to demographically similar PWOH…